Maternal Serum Fatty Acid Binding Protein 4 (FABP4) and the Development of Preeclampsia | Zendy

Christina Scifres | Zendy; Janet M. Catov | Zendy; Hyagriv N. Simhan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Maternal Serum Fatty Acid Binding Protein 4 (FABP4) and the Development of Preeclampsia

Author(s) -

Christina Scifres,

Janet M. Catov,

Hyagriv N. Simhan

Publication year - 2011

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2011-2276

Subject(s) - preeclampsia , medicine , gestation , dyslipidemia , insulin resistance , odds ratio , endocrinology , pregnancy , gestational age , obstetrics , body mass index , blood pressure , fatty acid binding protein , obesity , biology , genetics , biochemistry , gene

Serum fatty acid binding protein 4 (FABP4) is associated with components of the metabolic syndrome in nonpregnant individuals, including dyslipidemia and insulin resistance. Preeclampsia shares many features with the metabolic syndrome, but the relationship between early pregnancy serum FABP4 levels and the development of preeclampsia is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research